Welcome to LookChem.com Sign In|Join Free

CAS

  • or

267639-76-9

267639-76-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 267639-76-9 Structure

  • Basic information

    1. Product Name: Romiplostim
    2. Synonyms: Romiplostim;romiplostim(Nplate)
    3. CAS NO:267639-76-9
    4. Molecular Formula: C15H14N2O
    5. Molecular Weight: 238.28446
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 267639-76-9.mol
    9. Article Data: 0

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Romiplostim(CAS DataBase Reference)
    10. NIST Chemistry Reference: Romiplostim(267639-76-9)
    11. EPA Substance Registry System: Romiplostim(267639-76-9)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 267639-76-9(Hazardous Substances Data)

267639-76-9 Usage

Description

Romiplostim, also known as Nplate, is a recombinant fusion protein engineered as a peptibody that serves as a TPO receptor agonist. It is designed to contain two identical single-chain subunits, each consisting of a TPO-binding domain linked to the C-terminus of a human IgG1 Fc domain, which increases the half-life of the protein. Romiplostim is used for the treatment of thrombocytopenia in patients with ITP, an autoimmune blood disorder characterized by autoantibody-mediated platelet destruction and impaired platelet production.

Uses

Used in Pharmaceutical Industry:
Romiplostim is used as a TPO receptor agonist for the treatment of thrombocytopenia in patients with ITP. By binding to and activating the TPO receptor, it helps remediate the platelet production contribution of ITP and mitigates the risks associated with the first-generation predecessor, recombinant megakaryocyte growth and development factor (MGDF).
Additionally, romiplostim is used to avoid the side effects associated with generalized immunosuppressive agents previously employed for the treatment of ITP and may prevent splenectomy, another common treatment option.

Clinical Use

Fc-peptide fusion protein: Treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP)

Drug interactions

Potentially hazardous interactions with other drugs None known

Metabolism

Mainly renal clearance.

Check Digit Verification of cas no

The CAS Registry Mumber 267639-76-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,6,3 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 267639-76:
(8*2)+(7*6)+(6*7)+(5*6)+(4*3)+(3*9)+(2*7)+(1*6)=189
189 % 10 = 9
So 267639-76-9 is a valid CAS Registry Number.

267639-76-9Upstream product

267639-76-9Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 267639-76-9